Yee C, Meliadis C, Kaya S, Chang W, Alliston T
Front Endocrinol (Lausanne). 2024; 15:1342938.
PMID: 39092287
PMC: 11291448.
DOI: 10.3389/fendo.2024.1342938.
Sahbani K, Cardozo C, Bauman W, Tawfeek H
Physiol Rep. 2019; 7(19):e14225.
PMID: 31565870
PMC: 6766518.
DOI: 10.14814/phy2.14225.
Nishimori S, OMeara M, Castro C, Noda H, Cetinbas M, Da Silva Martins J
J Clin Invest. 2019; 129(12):5187-5203.
PMID: 31430259
PMC: 6877304.
DOI: 10.1172/JCI130126.
Li F, Cain J, Tombran-Tink J, Niyibizi C
Biochim Biophys Acta Mol Basis Dis. 2018; 1864(10):3449-3458.
PMID: 30076958
PMC: 6176723.
DOI: 10.1016/j.bbadis.2018.07.034.
Yu C, Xuan M, Zhang M, Yao Q, Zhang K, Zhang X
J Bone Miner Metab. 2017; 36(5):560-572.
PMID: 29124436
DOI: 10.1007/s00774-017-0873-0.
Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.
Tebben P, Singh R, Kumar R
Endocr Rev. 2016; 37(5):521-547.
PMID: 27588937
PMC: 5045493.
DOI: 10.1210/er.2016-1070.
Bone Matrix Composition Following PTH Treatment is Not Dependent on Sclerostin Status.
Ross R, Mashiatulla M, Robling A, Miller L, Sumner D
Calcif Tissue Int. 2015; 98(2):149-57.
PMID: 26514840
PMC: 7391132.
DOI: 10.1007/s00223-015-0074-6.
Osteocyte specific responses to soluble and mechanical stimuli in a stem cell derived culture model.
Thompson W, Uzer G, Brobst K, Xie Z, Sen B, Yen S
Sci Rep. 2015; 5:11049.
PMID: 26056071
PMC: 4460727.
DOI: 10.1038/srep11049.
Osteocyte-derived insulin-like growth factor I is not essential for the bone repletion response in mice.
Lau K, Baylink D, Sheng M
PLoS One. 2015; 10(1):e0115897.
PMID: 25635763
PMC: 4312049.
DOI: 10.1371/journal.pone.0115897.
Osteoblast-specific expression of the fibrous dysplasia (FD)-causing mutation Gsα(R201C) produces a high bone mass phenotype but does not reproduce FD in the mouse.
Remoli C, Michienzi S, Sacchetti B, Consiglio A, Cersosimo S, Spica E
J Bone Miner Res. 2014; 30(6):1030-43.
PMID: 25487351
PMC: 5526456.
DOI: 10.1002/jbmr.2425.
Alterations in vitamin D metabolite, parathyroid hormone and fibroblast growth factor-23 concentrations in sclerostin-deficient mice permit the maintenance of a high bone mass.
Ryan Z, Craig T, McGee-Lawrence M, Westendorf J, Kumar R
J Steroid Biochem Mol Biol. 2014; 148:225-31.
PMID: 25446885
PMC: 4361263.
DOI: 10.1016/j.jsbmb.2014.11.021.
A novel way to statistically analyze morphologic changes in Dmp1-null osteocytes.
Ren Y, Lin S, Jing Y, Dechow P, Feng J
Connect Tissue Res. 2014; 55 Suppl 1:129-33.
PMID: 25158197
PMC: 4638140.
DOI: 10.3109/03008207.2014.923879.
Reduced renal calcium excretion in the absence of sclerostin expression: evidence for a novel calcium-regulating bone kidney axis.
Kumar R, Vallon V
J Am Soc Nephrol. 2014; 25(10):2159-68.
PMID: 24876121
PMC: 4178449.
DOI: 10.1681/ASN.2014020166.
Once-Weekly Injection of Low-Dose Teriparatide (28.2 μg) Reduced the Risk of Vertebral Fracture in Patients with Primary Osteoporosis.
Fujita T, Fukunaga M, Itabashi A, Tsutani K, Nakamura T
Calcif Tissue Int. 2013; 94(2):170-5.
PMID: 23963633
PMC: 3899450.
DOI: 10.1007/s00223-013-9777-8.
The relation between renal function and serum sclerostin in adult patients with CKD.
Pelletier S, Dubourg L, Carlier M, Hadj-Aissa A, Fouque D
Clin J Am Soc Nephrol. 2013; 8(5):819-23.
PMID: 23430206
PMC: 3641616.
DOI: 10.2215/CJN.07670712.
Sclerostin antibody increases bone volume and enhances implant fixation in a rat model.
Virdi A, Liu M, Sena K, Maletich J, McNulty M, Ke H
J Bone Joint Surg Am. 2012; 94(18):1670-80.
PMID: 22992878
PMC: 3444952.
DOI: 10.2106/JBJS.K.00344.
Spinal cord injury-induced osteoporosis: pathogenesis and emerging therapies.
Battaglino R, Lazzari A, Garshick E, Morse L
Curr Osteoporos Rep. 2012; 10(4):278-85.
PMID: 22983921
PMC: 3508135.
DOI: 10.1007/s11914-012-0117-0.
Isolation and culture of primary osteocytes from the long bones of skeletally mature and aged mice.
Stern A, Stern M, Van Dyke M, Jahn K, Prideaux M, Bonewald L
Biotechniques. 2012; 52(6):361-73.
PMID: 22668415
PMC: 3612989.
DOI: 10.2144/0000113876.
Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo.
Woo S, Rosser J, Dusevich V, Kalajzic I, Bonewald L
J Bone Miner Res. 2011; 26(11):2634-46.
PMID: 21735478
PMC: 3192242.
DOI: 10.1002/jbmr.465.
G alpha(q) signal in osteoblasts is inhibitory to the osteoanabolic action of parathyroid hormone.
Ogata N, Shinoda Y, Wettschureck N, Offermanns S, Takeda S, Nakamura K
J Biol Chem. 2011; 286(15):13733-40.
PMID: 21345793
PMC: 3075717.
DOI: 10.1074/jbc.M110.200196.
